1.Barbut, F, Petit, JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7:405–410.
2.Kelly, CP, Pothoulakis, C, LaMont, JT. Clostridium difficile colitis. N Engl J Med 1994;330:257–262.
3.Cartmill, TD, Shrimpton, SB, Panigrahi, H, Khanna, V, Brown, R, Poxton, IR. Nosocomial diarrhoea due to a single strain of Clostridium difficile: a prolonged outbreak in elderly patients. Age Ageing 1992;21:245–249.
4.Johnson, S, Samore, MH, Farrow, KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999;341:1645–1651.
5.McFarland, LV, Mulligan, ME, Kwok, RY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320: 204-210.
6.Muto, CA, Pokrywka, M, Shutt, K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273–280.
7.Voth, DE, Ballard, JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005;18:247–263.
8.Popoff, MR, Rubin, EJ, Gill, DM, Boquet, P. Actin-specific ADP-ribosyl-transferase produced by a Clostridium difficile strain. Infect Immun 1988;56:2299–2306.
9.Perelle, S, Gibert, M, Bourlioux, P, Corthier, G, Popoff, MR. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 1997;65:1402–1407.
10.Geric, B, Rupnik, M, Gerding, DN, Grabnar, M, Johnson, S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 2004;53:887–894.
11.Goncalves, C, Deere, D, Barbut, F, Burghoffer, B, Petit, JC. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 2004;42:1933–1939.
12.Pituch, H, Rupnik, M, Obuch-Woszczatynski, P, Grubesic, A, Meisel-Mi-kolajczyk, F, Luczak, M. Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland. J Med Microbiol 2005;54:143–147.
13.Rupnik, M, Karo, N, Grabnar, M, Kato, H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003;41:1118–1125.
14.Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–2449.
15.McDonald, LC, Killgore, GE, Thompson, A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433–2441.
16.Pepin, J, Valiquette, L, Alary, ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Cmaj 2004;171:466–472.
17.Pepin, J, Valiquette, L, Cossette, B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Cmaj 2005;173:1037–1042.
18.Warny, M, Pepin, J, Fang, A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079–1084.
19.Kuijper, EJ, Van den Berg, RJ, Debast, S, et al. Clostridium difficile ribotype 027, toxinotype III, The Netherlands. Emerg Infect Dis 2006;12:827–830.
20.Barbut, F, Depitre, C, Delmee, M, Corthier, G, Petit, JC. Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients. J Clin Microbiol 1993;31:740–742.
21.Delmee, M, Depitre, C, Corthier, G, Ahoyo, A, Avesani, V. Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping. J Clin Microbiol 1993;31:2526–2528.
22.Stubbs, S, Rupnik, M, Gibert, M, Brazier, J, Duerden, B, Popoff, M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000;186:307–312.
23.Rupnik, M, Avesani, V, Jane, M, von Eichel-Streiber, C, Delmee, M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 1998;36:2240–2247.
24.Rupnik, M. How to detect Clostridium difficile variant strains in a routine laboratory. Clin Microbiol Infect 2001;7:417–420.
26.Spigaglia, P, Mastrantonio, P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002;40:3470–3475.
27.Bidet, P, Lalande, V, Salauze, B, et al. Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 2000;38:2484–2487.
28.Barbut, F, Leluan, P, Antoniotti, G, Collignon, A, Sedallian, A, Petit, JC. Value of routine stool cultures in hospitalized patients with diarrhea. Eur J Clin Microbiol Infect Dis 1995;14:346–349.
29.Siegel, DL, Edelstein, PH, Nachamkin, I. Inappropriate testing for diarrheal diseases in the hospital. Jama 1990;263:979–982.
30.Rohner, P, Pittet, D, Pepey, B, Nije-Kinge, T, Auckenthaler, R. Etiological agents of infectious diarrhea: implications for requests for microbial culture. J Clin Microbiol 1997;35:1427–1432.
31.Barbut, F, Delmee, M, Brazier, JS, et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 2003;9:989–996.
32.Archibald, LK, Banerjee, SN, Jarvis, WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:1585–1589.
33.Olson, MM, Shanholtzer, CJ, Lee, JT Jr, Gerding, DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994;15:371–381.
34.Delmee, M, Van Broeck, J, Simon, A, Janssens, M, Avesani, V. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 2005;54:187–191.
35.Gerding, DN, Olson, MM, Peterson, LR, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med 1986;146:95–100.
36.Barbut, F, Lalande, V, Burghoffer, B, Thien, HV, Grimprel, E, Petit, JC. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 2002;40:2079–2083.
37.Brazier, JS, Stubbs, SL, Duerden, BI. Prevalence of toxin A negative/B positive Clostridium difficile strains. J Hosp Infect 1999;42:248–249.
38.Kato, H, Kato, N, Watanabe, K, et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 1998;36:2178–2182.
39.Drudy, D, Harnedy, N, Fanning, S, O'Mahoney, R, Baird, A, Kyne, L. Endemic toxin variant in a Irish teaching hospital. In: Program and Abstracts of the 1st International Clostridium difficile Symposium (Kranjska-Gora, Slovenia). Lubljana, Slovenia: M. Rupnik, 2004:44. Abstract 2.
40.Miller, MA, Hyland, M, Ofner-Agostini, M, Gourdeau, M, Ishak, M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002;23:137–140.
41.Barbut, F, Richard, A, Hamadi, K, Chomette, V, Burghoffer, B, Petit, JC. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000;38:2386–2388.
42.Svenungsson, B, Burman, LG, Jalakas-Pornull, K, Lagergren, A, Struwe, J, Akerlund, T. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. Clin Microbiol 2003;41:4031–4037.
43.Clabots, CR, Johnson, S, Olson, MM, Peterson, LR, Gerding, DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166:561–567.
44.Stubbs, SL, Brazier, JS, O'Neill, GL, Duerden, BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999;37:461–463.
45.Pituch, H, Kreft, D, Obuch-Woszczatynski, P, et al. Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea. J Clin Microbiol 2005;43:472–475.
46.Barbut, F, Deere, D, Lalande, V, et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)–producing strains. J Med Microbiol 2005;54:181–185.
47.Geric, B, Carman, RJ, Rupnik, M, et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 2006;193:1143–1150.